All AbMole products are for research use only, cannot be used for human consumption.
Levetiracetam (UCB L059) is an antiepileptic, it is also a selective M2 muscarinic acetylcholine receptors (mAChR) inhibitor. Levetiracetam displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Levetiracetam binds synaptic vesicle protein 2A (SV2A).
| Molecular Weight | 170.21 |
| Formula | C8H14N2O2 |
| CAS Number | 102767-28-2 |
| Solubility (25°C) | DMSO ≥ 30 mg/mL Water ≥ 30 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related AChR/AChE Products |
|---|
| 1-Benzyl-1H-indole-2,3-dione
1-Benzyl-1H-indole-2,3-dione |
| VU 0255035
VU 0255035 is a highly selective M1 muscarinic acetylcholine receptor (mAChR) antagonist (Ki = 14.87 nM). |
| Fesoterodine fumarate
Fesoterodine fumarate (Toviaz) is a novel muscarinic receptor antagonist. |
| SVT-40776
SVT-40776 is a novel M3 muscarinic receptor antagonist. |
| Aniracetam
Aniracetam is a compound that promotes intellectual development and neuroprotection. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
